275 related articles for article (PubMed ID: 9298733)
21. Varicella Virus Vaccination in the United States.
Shaw J; Gershon AA
Viral Immunol; 2018 Mar; 31(2):96-103. PubMed ID: 29173081
[TBL] [Abstract][Full Text] [Related]
22. Preventing varicella-zoster disease.
Hambleton S; Gershon AA
Clin Microbiol Rev; 2005 Jan; 18(1):70-80. PubMed ID: 15653819
[TBL] [Abstract][Full Text] [Related]
23. Monitoring virus strain variation following infection with VZV: is there a need and what are the implications of introducing the Oka vaccine?
Breuer J
Commun Dis Public Health; 2003 Apr; 6(1):59-62. PubMed ID: 12736975
[TBL] [Abstract][Full Text] [Related]
24. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
Freer G; Pistello M
New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
[TBL] [Abstract][Full Text] [Related]
25. Live attenuated varicella vaccine.
Arvin AM; Gershon AA
Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
[TBL] [Abstract][Full Text] [Related]
26. Differentiation between wild-type and vaccines strains of varicella zoster virus (VZV) based on four single nucleotide polymorphisms.
Jin L; Xu S; Maple PAC; Xu W; Brown KE
Epidemiol Infect; 2017 Sep; 145(12):2618-2625. PubMed ID: 28748773
[TBL] [Abstract][Full Text] [Related]
27. Cycling probe technology to quantify and discriminate between wild-type varicella-zoster virus and Oka vaccine strains.
Ihira M; Higashimoto Y; Kawamura Y; Sugata K; Ohashi M; Asano Y; Yoshikawa T
J Virol Methods; 2013 Nov; 193(2):308-13. PubMed ID: 23820238
[TBL] [Abstract][Full Text] [Related]
28. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.
Weinmann S; Chun C; Schmid DS; Roberts M; Vandermeer M; Riedlinger K; Bialek SR; Marin M
J Infect Dis; 2013 Dec; 208(11):1859-68. PubMed ID: 23922376
[TBL] [Abstract][Full Text] [Related]
29. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.
Uebe B; Sauerbrei A; Burdach S; Horneff G
Eur J Pediatr; 2002 Aug; 161(8):442-4. PubMed ID: 12172829
[TBL] [Abstract][Full Text] [Related]
30. Varicella-zoster virus vaccine: molecular genetics.
Schmid DS
Curr Top Microbiol Immunol; 2010; 342():323-40. PubMed ID: 20225010
[TBL] [Abstract][Full Text] [Related]
31. A real-time PCR assay for the detection of varicella-zoster virus DNA and differentiation of vaccine, wild-type and control strains.
Tipples GA; Safronetz D; Gray M
J Virol Methods; 2003 Nov; 113(2):113-6. PubMed ID: 14553897
[TBL] [Abstract][Full Text] [Related]
32. Universal varicella vaccine immunization in Japan.
Yoshikawa T; Kawamura Y; Ohashi M
Vaccine; 2016 Apr; 34(16):1965-70. PubMed ID: 26944711
[TBL] [Abstract][Full Text] [Related]
33. [Genotyping of varicella zoster virus strains isolated in Mongolia].
Enskhsaĭkhan D; Loparev VN; Bostik V; Tuul P; Darmaa B; Demkin VV; Niamdavaa P
Vopr Virusol; 2010; 55(5):40-3. PubMed ID: 21260996
[TBL] [Abstract][Full Text] [Related]
34. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.
Argaw T; Cohen JI; Klutch M; Lekstrom K; Yoshikawa T; Asano Y; Krause PR
J Infect Dis; 2000 Mar; 181(3):1153-7. PubMed ID: 10720545
[TBL] [Abstract][Full Text] [Related]
35. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
[TBL] [Abstract][Full Text] [Related]
36. Amplification and sequencing of varicella-zoster virus (VZV) gene 4: point mutation in a VZV strain causing chickenpox during pregnancy.
Chow VT; Lim KP
Acta Virol; 1997 Oct; 41(5):277-83. PubMed ID: 9607081
[TBL] [Abstract][Full Text] [Related]
37. Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease HpaI.
Hayakawa Y; Yamamoto T; Yamanishi K; Takahashi M
J Gen Virol; 1986 Sep; 67 ( Pt 9)():1817-29. PubMed ID: 3018125
[TBL] [Abstract][Full Text] [Related]
38. [Vaccines against varicella-zoster virus (VZV)].
Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
[TBL] [Abstract][Full Text] [Related]
39. The varicella vaccine. Vaccine development.
Takahashi M
Infect Dis Clin North Am; 1996 Sep; 10(3):469-88. PubMed ID: 8856348
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterisation of varicella zoster virus genotypes in Sri Lanka.
Lohitharajah J; Malavige GN; Wijewickrama A; Ambagawita A; Seneviratne AL; Ogg G
Ceylon Med J; 2013 Dec; 58(4):153-6. PubMed ID: 24385056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
